Genus Lifesciences Inc.

Form 483 issued September 20, 2019 · Allentown, Pennsylvania

Inspection
Sep 9 – Sep 20, 2019
Investigator
David A. Oluwo
Observations
3
Pages
3
FEI number
3003851100

In short: On September 20, 2019, FDA issued a Form 483 with 3 observations to Genus Lifesciences Inc. in Allentown, Pennsylvania (FEI 3003851100) after an inspection that ran Sep 9 – Sep 20, 2019. The investigator was David A. Oluwo. Most observations concern quality system and production.

At a glance

Quality system and production account for 2 of 3 observations.

Quality system1
Production1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    There are no written procedures for production and process controls designed to assure that the drug…

  3. 03

    An ND A-Field Alert Report was not submitted within three working days of receipt of information…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Genus Lifesciences Inc.?

FDA listed 3 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected Genus Lifesciences Inc.?

David A. Oluwo is named on this Form 483, for the inspection of Sep 9 – Sep 20, 2019. Each investigator has a profile showing what they cite most.

When was Genus Lifesciences Inc. inspected by FDA?

The inspection ran Sep 9 – Sep 20, 2019, and the Form 483 is dated September 20, 2019.

How do I get the full Form 483 for Genus Lifesciences Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free